ATTN: #EliLilly RE: #Mounjaro and #Zepbound #releasethevials #mounjaroshortage #zepboundshortage #medtok #onthepen The US Food and Drug Administration approved single-use vials for Zepbound late ...

When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he knew he had to take action. Here’s what happened when he turned to injectables ...

The FDA clarifies that both Mounjaro single-dose vial products, which were approved in July 2023 (supplement to NDA 215866), and Zepbound single-dose vials, which were approved in March 2024 ...

Mounjaro has already been launched in other European markets, including Germany, Switzerland, and Poland, according to a Reuters report, but has initially been made available in vials only as ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says. Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025.

"Ozempic is the only version among the weekly injectables — Ozempic, Wegovy, Zepbound and Mounjaro — that has ... versions are usually dispensed in vials, which requires a syringe to draw ...

Vials of Mounjaro, the type 2 diabetes drug Mounjaro which has been recommended to help obese people lose weight on the NHS Alamy/PA Starting on a low dose (2.5mg), I inject into my belly fat once ...